| 1 | Mitochondrion 2009 Nov 9: 385-93 |
|---|---|
| PMID | 19563917 |
| Title | Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. |
| Abstract | To test the hypothesis that mitochondrial DNA (mtDNA) variants contribute to the susceptibility toschizophrenia, we sequenced the entire mtDNAs from 93 Japaneseschizophrenicpatients. Three non-synonymous homoplasmic variants in subunit six of the ATP synthase (MT-ATP6) gene that were detected only in patients but not in controls were suggested to be slightly deleterious, because (1) their original amino acid residues (AA) were highly conserved and (2) the physicochemical differences between the original and altered AA were relatively high. In addition, we detected three novel heteroplasmic variants that were potentially pathogenic. Although functional analysis is needed, rare variants in the mtDNA may convey susceptibility toschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 2 | Mitochondrion 2009 Nov 9: 385-93 |
| PMID | 19563917 |
| Title | Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. |
| Abstract | To test the hypothesis that mitochondrial DNA (mtDNA) variants contribute to the susceptibility toschizophrenia, we sequenced the entire mtDNAs from 93 Japaneseschizophrenicpatients. Three non-synonymous homoplasmic variants in subunit six of the ATP synthase (MT-ATP6) gene that were detected only in patients but not in controls were suggested to be slightly deleterious, because (1) their original amino acid residues (AA) were highly conserved and (2) the physicochemical differences between the original and altered AA were relatively high. In addition, we detected three novel heteroplasmic variants that were potentially pathogenic. Although functional analysis is needed, rare variants in the mtDNA may convey susceptibility toschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 3 | Mitochondrion 2009 Nov 9: 385-93 |
| PMID | 19563917 |
| Title | Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. |
| Abstract | To test the hypothesis that mitochondrial DNA (mtDNA) variants contribute to the susceptibility toschizophrenia, we sequenced the entire mtDNAs from 93 Japaneseschizophrenicpatients. Three non-synonymous homoplasmic variants in subunit six of the ATP synthase (MT-ATP6) gene that were detected only in patients but not in controls were suggested to be slightly deleterious, because (1) their original amino acid residues (AA) were highly conserved and (2) the physicochemical differences between the original and altered AA were relatively high. In addition, we detected three novel heteroplasmic variants that were potentially pathogenic. Although functional analysis is needed, rare variants in the mtDNA may convey susceptibility toschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 4 | Mitochondrion 2009 Nov 9: 385-93 |
| PMID | 19563917 |
| Title | Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. |
| Abstract | To test the hypothesis that mitochondrial DNA (mtDNA) variants contribute to the susceptibility toschizophrenia, we sequenced the entire mtDNAs from 93 Japaneseschizophrenicpatients. Three non-synonymous homoplasmic variants in subunit six of the ATP synthase (MT-ATP6) gene that were detected only in patients but not in controls were suggested to be slightly deleterious, because (1) their original amino acid residues (AA) were highly conserved and (2) the physicochemical differences between the original and altered AA were relatively high. In addition, we detected three novel heteroplasmic variants that were potentially pathogenic. Although functional analysis is needed, rare variants in the mtDNA may convey susceptibility toschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 5 | Mitochondrion 2009 Nov 9: 385-93 |
| PMID | 19563917 |
| Title | Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. |
| Abstract | To test the hypothesis that mitochondrial DNA (mtDNA) variants contribute to the susceptibility toschizophrenia, we sequenced the entire mtDNAs from 93 Japaneseschizophrenicpatients. Three non-synonymous homoplasmic variants in subunit six of the ATP synthase (MT-ATP6) gene that were detected only in patients but not in controls were suggested to be slightly deleterious, because (1) their original amino acid residues (AA) were highly conserved and (2) the physicochemical differences between the original and altered AA were relatively high. In addition, we detected three novel heteroplasmic variants that were potentially pathogenic. Although functional analysis is needed, rare variants in the mtDNA may convey susceptibility toschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 6 | Mitochondrion 2009 Nov 9: 385-93 |
| PMID | 19563917 |
| Title | Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. |
| Abstract | To test the hypothesis that mitochondrial DNA (mtDNA) variants contribute to the susceptibility toschizophrenia, we sequenced the entire mtDNAs from 93 Japaneseschizophrenicpatients. Three non-synonymous homoplasmic variants in subunit six of the ATP synthase (MT-ATP6) gene that were detected only in patients but not in controls were suggested to be slightly deleterious, because (1) their original amino acid residues (AA) were highly conserved and (2) the physicochemical differences between the original and altered AA were relatively high. In addition, we detected three novel heteroplasmic variants that were potentially pathogenic. Although functional analysis is needed, rare variants in the mtDNA may convey susceptibility toschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 7 | Am. J. Med. Genet. B Neuropsychiatr. Genet. 2014 Oct 165B: 607-17 |
| PMID | 25132006 |
| Title | 线粒体DNA (mtDNA) variants in the European haplogroups HV, JT, and U do not have a major role in schizophrenia. |
| Abstract | It has been reported that certain genetic factors involved inschizophreniacould be located in the mitochondrial DNA (mtDNA). Therefore, we hypothesized that mtDNA mutations and/or variants would be present inschizophreniapatients and may be related toschizophreniacharacteristics and mitochondrial function. This study was performed in three steps: (1) identification of pathogenic mutations and variants in 14schizophreniapatients with an apparent maternal inheritance of the disease by sequencing the entire mtDNA; (2) case-control association study of 23 variants identified in step 1 (16 missense, 3 rRNA, and 4 tRNA variants) in 495 patients and 615 controls, and (3) analyses of the associated variants according to the clinical, psychopathological, and neuropsychological characteristics and according to the oxidative and enzymatic activities of the mitochondrial respiratory chain. We did not identify pathogenic mtDNA mutations in the 14 sequenced patients. Two known variants were nominally associated withschizophreniaand were further studied. The MT-RNR2 1811A?>?G variant likely does not play a major role inschizophrenia, as it was not associated with clinical, psychopathological, or neuropsychological variables, and the MT-ATP69110T?>?C p.Ile195Thr variant did not result in differences in the oxidative and enzymatic functions of the mitochondrial respiratory chain. The patients with apparent maternal inheritance ofschizophreniadid not exhibit any mutations in their mtDNA. The variants nominally associated withschizophreniain the present study were not related either to phenotypic characteristics or to mitochondrial function. We did not find evidence pointing to a role for mtDNA sequence variation inschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 8 | Am. J. Med. Genet. B Neuropsychiatr. Genet. 2014 Oct 165B: 607-17 |
| PMID | 25132006 |
| Title | 线粒体DNA (mtDNA) variants in the European haplogroups HV, JT, and U do not have a major role in schizophrenia. |
| Abstract | It has been reported that certain genetic factors involved inschizophreniacould be located in the mitochondrial DNA (mtDNA). Therefore, we hypothesized that mtDNA mutations and/or variants would be present inschizophreniapatients and may be related toschizophreniacharacteristics and mitochondrial function. This study was performed in three steps: (1) identification of pathogenic mutations and variants in 14schizophreniapatients with an apparent maternal inheritance of the disease by sequencing the entire mtDNA; (2) case-control association study of 23 variants identified in step 1 (16 missense, 3 rRNA, and 4 tRNA variants) in 495 patients and 615 controls, and (3) analyses of the associated variants according to the clinical, psychopathological, and neuropsychological characteristics and according to the oxidative and enzymatic activities of the mitochondrial respiratory chain. We did not identify pathogenic mtDNA mutations in the 14 sequenced patients. Two known variants were nominally associated withschizophreniaand were further studied. The MT-RNR2 1811A?>?G variant likely does not play a major role inschizophrenia, as it was not associated with clinical, psychopathological, or neuropsychological variables, and the MT-ATP69110T?>?C p.Ile195Thr variant did not result in differences in the oxidative and enzymatic functions of the mitochondrial respiratory chain. The patients with apparent maternal inheritance ofschizophreniadid not exhibit any mutations in their mtDNA. The variants nominally associated withschizophreniain the present study were not related either to phenotypic characteristics or to mitochondrial function. We did not find evidence pointing to a role for mtDNA sequence variation inschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 9 | Am. J. Med. Genet. B Neuropsychiatr. Genet. 2014 Oct 165B: 607-17 |
| PMID | 25132006 |
| Title | 线粒体DNA (mtDNA) variants in the European haplogroups HV, JT, and U do not have a major role in schizophrenia. |
| Abstract | It has been reported that certain genetic factors involved inschizophreniacould be located in the mitochondrial DNA (mtDNA). Therefore, we hypothesized that mtDNA mutations and/or variants would be present inschizophreniapatients and may be related toschizophreniacharacteristics and mitochondrial function. This study was performed in three steps: (1) identification of pathogenic mutations and variants in 14schizophreniapatients with an apparent maternal inheritance of the disease by sequencing the entire mtDNA; (2) case-control association study of 23 variants identified in step 1 (16 missense, 3 rRNA, and 4 tRNA variants) in 495 patients and 615 controls, and (3) analyses of the associated variants according to the clinical, psychopathological, and neuropsychological characteristics and according to the oxidative and enzymatic activities of the mitochondrial respiratory chain. We did not identify pathogenic mtDNA mutations in the 14 sequenced patients. Two known variants were nominally associated withschizophreniaand were further studied. The MT-RNR2 1811A?>?G variant likely does not play a major role inschizophrenia, as it was not associated with clinical, psychopathological, or neuropsychological variables, and the MT-ATP69110T?>?C p.Ile195Thr variant did not result in differences in the oxidative and enzymatic functions of the mitochondrial respiratory chain. The patients with apparent maternal inheritance ofschizophreniadid not exhibit any mutations in their mtDNA. The variants nominally associated withschizophreniain the present study were not related either to phenotypic characteristics or to mitochondrial function. We did not find evidence pointing to a role for mtDNA sequence variation inschizophrenia. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 10 | PLoS ONE 2015 -1 10: e0127280 |
| PMID | 26011537 |
| Title | Mitochondrial mutations in subjects with psychiatric disorders. |
| Abstract | A considerable body of evidence supports the role of mitochondrial dysfunction in psychiatric disorders and mitochondrial DNA (mtDNA) mutations are known to alter brain energy metabolism, neurotransmission, and cause neurodegenerative disorders. Genetic studies focusing on common nuclear genome variants associated with these disorders have produced genome wide significant results but those studies have not directly studied mtDNA variants. The purpose of this study is to investigate, using next generation sequencing, the involvement of mtDNA variation in bipolar disorder,schizophrenia, major depressive disorder, and methamphetamine use. MtDNA extracted from multiple brain regions and blood were sequenced (121 mtDNA samples with an average of 8,800x coverage) and compared to an electronic database containing 26,850 mtDNA genomes. We confirmed novel and rare variants, and confirmed next generation sequencing error hotspots by traditional sequencing and genotyping methods. We observed a significant increase of non-synonymous mutations found in individuals withschizophrenia. Novel and rare non-synonymous mutations were found in psychiatric cases in mtDNA genes: ND6,ATP6, CYTB, and ND2. We also observed mtDNA heteroplasmy in brain at a locus previously associated withschizophrenia(T16519C). Large differences in heteroplasmy levels across brain regions within subjects suggest that somatic mutations accumulate differentially in brain regions. Finally, multiplasmy, a heteroplasmic measure of repeat length, was observed in brain from selective cases at a higher frequency than controls. These results offer support for increased rates of mtDNA substitutions inschizophreniashown in our prior results. The variable levels of heteroplasmic/multiplasmic somatic mutations that occur in brain may be indicators of genetic instability in mtDNA. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 11 | PLoS ONE 2015 -1 10: e0127280 |
| PMID | 26011537 |
| Title | Mitochondrial mutations in subjects with psychiatric disorders. |
| Abstract | A considerable body of evidence supports the role of mitochondrial dysfunction in psychiatric disorders and mitochondrial DNA (mtDNA) mutations are known to alter brain energy metabolism, neurotransmission, and cause neurodegenerative disorders. Genetic studies focusing on common nuclear genome variants associated with these disorders have produced genome wide significant results but those studies have not directly studied mtDNA variants. The purpose of this study is to investigate, using next generation sequencing, the involvement of mtDNA variation in bipolar disorder,schizophrenia, major depressive disorder, and methamphetamine use. MtDNA extracted from multiple brain regions and blood were sequenced (121 mtDNA samples with an average of 8,800x coverage) and compared to an electronic database containing 26,850 mtDNA genomes. We confirmed novel and rare variants, and confirmed next generation sequencing error hotspots by traditional sequencing and genotyping methods. We observed a significant increase of non-synonymous mutations found in individuals withschizophrenia. Novel and rare non-synonymous mutations were found in psychiatric cases in mtDNA genes: ND6,ATP6, CYTB, and ND2. We also observed mtDNA heteroplasmy in brain at a locus previously associated withschizophrenia(T16519C). Large differences in heteroplasmy levels across brain regions within subjects suggest that somatic mutations accumulate differentially in brain regions. Finally, multiplasmy, a heteroplasmic measure of repeat length, was observed in brain from selective cases at a higher frequency than controls. These results offer support for increased rates of mtDNA substitutions inschizophreniashown in our prior results. The variable levels of heteroplasmic/multiplasmic somatic mutations that occur in brain may be indicators of genetic instability in mtDNA. |
| SCZ Keywords | schizophrenia, schizophrenic |
| 12 | PLoS ONE 2015 -1 10: e0127280 |
| PMID | 26011537 |
| Title | Mitochondrial mutations in subjects with psychiatric disorders. |
| Abstract | A considerable body of evidence supports the role of mitochondrial dysfunction in psychiatric disorders and mitochondrial DNA (mtDNA) mutations are known to alter brain energy metabolism, neurotransmission, and cause neurodegenerative disorders. Genetic studies focusing on common nuclear genome variants associated with these disorders have produced genome wide significant results but those studies have not directly studied mtDNA variants. The purpose of this study is to investigate, using next generation sequencing, the involvement of mtDNA variation in bipolar disorder,schizophrenia, major depressive disorder, and methamphetamine use. MtDNA extracted from multiple brain regions and blood were sequenced (121 mtDNA samples with an average of 8,800x coverage) and compared to an electronic database containing 26,850 mtDNA genomes. We confirmed novel and rare variants, and confirmed next generation sequencing error hotspots by traditional sequencing and genotyping methods. We observed a significant increase of non-synonymous mutations found in individuals withschizophrenia. Novel and rare non-synonymous mutations were found in psychiatric cases in mtDNA genes: ND6,ATP6, CYTB, and ND2. We also observed mtDNA heteroplasmy in brain at a locus previously associated withschizophrenia(T16519C). Large differences in heteroplasmy levels across brain regions within subjects suggest that somatic mutations accumulate differentially in brain regions. Finally, multiplasmy, a heteroplasmic measure of repeat length, was observed in brain from selective cases at a higher frequency than controls. These results offer support for increased rates of mtDNA substitutions inschizophreniashown in our prior results. The variable levels of heteroplasmic/multiplasmic somatic mutations that occur in brain may be indicators of genetic instability in mtDNA. |
| SCZ Keywords | schizophrenia, schizophrenic |